Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Lynnette Fernandez-Cuesta

Computational Cancer Genomics Team leader

International Agency for Research on Cancer

France

Research Interests

Explore related searches

Professors in France Professors in Cell Biology Cell Biology professors in France

Articles (14)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (13)

Marco A. Calzado

Full Professor

Universidad de Córdoba

SPAIN

View details

Antonella Dost

Associate Professor

Københavns Universitet

DENMARK

View details

Nicolas Alcala

Professional Scientist

International Agency for Research on Cancer

FRANCE

View details

Marco Volante

ITALY

View details

Mirja Rotinen

Public University of Navarre

SPAIN

View details

Luka Brcic

Medical University of Graz

AUSTRIA

View details

Eric Lim

Professor of Thoracic Surgery

Imperial College London

UNITED KINGDOM

View details

Halfdan Sorbye

NORWAY

View details

Brivael Hémon

Enseignant-chercheur

École des Hautes Études en Santé Publique

FRANCE

View details

Benjamin Gibert

Centre de Recherche en Cancérologie de Lyon

FRANCE

View details

Dagfinn Aune

Associate Professor

NORWAY

View details

Matthieu Foll

Team Leader

International Agency for Research on Cancer

FRANCE

View details

Jaehee Kim

Assistant Professor

Cornell University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lynnette Fernandez-Cuesta

Research Interests

Explore related searches

Articles (14)

Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management

The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research.

ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer.

Controversies in NEN: An ENETS position statement on the treatment of patients with Grade 3 well-differentiated neuroendocrine tumours of the gastro-enteropancreatic tract.

Basic science and translational implications of current knowledge on neuroendocrine tumors.

Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms

Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project

Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force.

Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids.

<i>TERT</i> Expression and Clinical Outcome in Pulmonary Carcinoids.

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery

Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites.

Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms.

Collaborators (13)

Marco A. Calzado

Antonella Dost

Nicolas Alcala

Marco Volante

Mirja Rotinen

Luka Brcic

Eric Lim

Halfdan Sorbye

Brivael Hémon

Benjamin Gibert

Dagfinn Aune

Matthieu Foll

Jaehee Kim

Make your next move.

Lynnette Fernandez-Cuesta

Research Interests

Explore related searches

Articles (14)

Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management

The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research.

ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer.

Controversies in NEN: An ENETS position statement on the treatment of patients with Grade 3 well-differentiated neuroendocrine tumours of the gastro-enteropancreatic tract.

Basic science and translational implications of current knowledge on neuroendocrine tumors.

Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms

Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project

Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force.

Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids.

&lt;i&gt;TERT&lt;/i&gt; Expression and Clinical Outcome in Pulmonary Carcinoids.

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery

Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites.

Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms.

Collaborators (13)

Marco A. Calzado

Antonella Dost

Nicolas Alcala

Marco Volante

Mirja Rotinen

Luka Brcic

Eric Lim

Halfdan Sorbye

Brivael Hémon

Benjamin Gibert

Dagfinn Aune

Matthieu Foll

Jaehee Kim

Make your next move.

<i>TERT</i> Expression and Clinical Outcome in Pulmonary Carcinoids.